Premium
Population pharmacokinetic (PopPK) modelling indicates that patients switching to BAY 81‐8973 from rFVIII‐FS can continue their dosing schedule with improved protection
Author(s) -
Solms Alexander,
Lalezari Shadan,
Shah Anita,
Kenet Gili
Publication year - 2020
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/hae.13973
Subject(s) - medicine , dosing , schedule , population , pharmacokinetics , intensive care medicine , environmental health , pharmacology , computer science , operating system